본문으로 건너뛰기
← 뒤로

Pulmonary Mass as the First Clinical Manifestation of Histiocytic Sarcoma with Multi-Organ Involvement: A Case Report and Review of the Literature.

International journal of surgical pathology 2026 Vol.34(1) p. 255-262

Liu LW, Liang JS, Chen CC, Chuang HW

📝 환자 설명용 한 줄

Histiocytic sarcoma is a malignant neoplasm with cells showing morphologic and immunohistochemical features of histiocytes.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Liu LW, Liang JS, et al. (2026). Pulmonary Mass as the First Clinical Manifestation of Histiocytic Sarcoma with Multi-Organ Involvement: A Case Report and Review of the Literature.. International journal of surgical pathology, 34(1), 255-262. https://doi.org/10.1177/10668969251362195
MLA Liu LW, et al.. "Pulmonary Mass as the First Clinical Manifestation of Histiocytic Sarcoma with Multi-Organ Involvement: A Case Report and Review of the Literature.." International journal of surgical pathology, vol. 34, no. 1, 2026, pp. 255-262.
PMID 40808572

Abstract

Histiocytic sarcoma is a malignant neoplasm with cells showing morphologic and immunohistochemical features of histiocytes. The lung and stomach are rare sites of involvement, and few have been reported in the existing literature. We report a 72-year-old woman with primary histiocytic sarcoma involving the right lung, stomach, and bilateral adrenal glands. Computed tomography revealed a large heterogeneous mass in the upper lobe of the right lung, regional lymphadenopathy, and masses within the bilateral adrenal glands. Gastric involvement was discovered via polypectomy during a routine gastric endoscopy. Morphologically, the lung and stomach specimens showed sheets of large and spindle cells with increased mitotic figures. Immunohistochemical staining revealed CD163, CD68, and CD4 expression in the lung tumor and CD163 and CD4 in the gastric tumor. The patient deteriorated rapidly and died of a pulmonary infection two months after diagnosis. Surgical resection remains the most effective treatment. However, for those with advanced disease, systemic chemotherapy alone may be the only available option, but the outcomes are variable. Advancements in targeted therapy are needed to improve treatment outcomes for patients with multi-organ involvement of histiocytic sarcoma.

MeSH Terms

Humans; Female; Aged; Histiocytic Sarcoma; Lung Neoplasms; Stomach Neoplasms; Adrenal Gland Neoplasms; Fatal Outcome; Biomarkers, Tumor; Lung; Tomography, X-Ray Computed

같은 제1저자의 인용 많은 논문 (2)